A substance abuse treatment provider and its former chief executive officer will pay $627,000 to resolve allegations they violated the False Claims Act.
The government claims The Hartford Dispensary, the Hartford Dispensary Endowment Corp. and former CEO Paul McLaughlin made “repeated false representations” to federal and state authorities that the company had a medical director who performed duties required by federal law. The company also allegedly submitted fraudulent Medicaid claims.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
